Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1209-20. doi: 10.1161/ATVBAHA.113.302878. Epub 2014 Apr 10.

Abstract

Objective: The Cxcl12/Cxcr4 chemokine ligand/receptor axis mediates the mobilization of smooth muscle cell progenitors, driving injury-induced neointimal hyperplasia. This study aimed to investigate the role of endothelial Cxcr4 in neointima formation.

Approach and results: β-Galactosidase staining using bone marrow x kinase (Bmx)-CreER(T2) reporter mice and double immunofluorescence revealed an efficient and endothelial-specific deletion of Cxcr4 in Bmx-CreER(T2+) compared with Bmx-CreER(T2-) Cxcr4-floxed apolipoprotein E-deficient (Apoe(-/-)) mice (referred to as Cxcr4(EC-KO)ApoE(-/-) and Cxcr4(EC-WT) ApoE(-/-), respectively). Endothelial Cxcr4 deficiency significantly increased wire injury-induced neointima formation in carotid arteries from Cxcr4(EC-KO)ApoE(-/-) mice. The lesions displayed a higher number of macrophages, whereas the smooth muscle cell and collagen content were reduced. This was associated with a significant reduction in reendothelialization and endothelial cell proliferation in injured Cxcr4(EC-KO)ApoE(-/-) carotids compared with Cxcr4(EC-WT)ApoE(-/-) controls. Furthermore, stimulation of human aortic endothelial cells with chemokine (C-X-C motif) ligand 12 (CXCL12) significantly enhanced their wound-healing capacity in an in vitro scratch assay, an effect that could be reversed with the CXCR4 antagonist AMD3100. Also, flow cytometric analysis showed a reduced mobilization of Sca1(+)Flk1(+)Cd31(+) and of Lin(-)Sca1(+) progenitors in Cxcr4(EC-KO) ApoE(-/-) mice after vascular injury, although Cxcr4 surface expression was unaltered. No differences could be detected in plasma concentrations of Cxcl12, vascular endothelial growth factor, sphingosine 1-phosphate, or Flt3 (fms-related tyrosine kinase 3) ligand, all cytokines with an established role in progenitor cell mobilization. Nonetheless, double immunofluorescence revealed a significant reduction in local endothelial Cxcl12 staining in injured carotids from Cxcr4(EC-KO)ApoE(-/-) mice.

Conclusions: Endothelial Cxcr4 is crucial for efficient reendothelialization after vascular injury through endothelial wound healing and proliferation, and through the mobilization of Sca1(+)Flk1(+)Cd31(+) cells, often referred to as circulating endothelial progenitor cells.

Keywords: chemokine Cxcl12; progenitor cells; receptors, Cxcr4; restenosis; vascular biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Ly / physiology
  • Apolipoproteins E / physiology
  • Atherosclerosis / pathology*
  • Atherosclerosis / physiopathology
  • Carotid Artery Injuries / pathology*
  • Cell Movement
  • Chemokine CXCL12 / physiology
  • Endothelial Cells / physiology*
  • Female
  • Hyperplasia
  • Membrane Proteins / physiology
  • Mice
  • Mice, Inbred C57BL
  • Neointima / pathology*
  • Protein-Tyrosine Kinases / physiology
  • Receptors, CXCR4 / physiology*
  • Vascular Endothelial Growth Factor Receptor-2 / physiology

Substances

  • Antigens, Ly
  • Apolipoproteins E
  • CXCR4 protein, mouse
  • Chemokine CXCL12
  • Ly6a protein, mouse
  • Membrane Proteins
  • Receptors, CXCR4
  • Bmx protein, mouse
  • Protein-Tyrosine Kinases
  • Vascular Endothelial Growth Factor Receptor-2